Why Ultragenyx Pharmaceutical Stock Is Spiking Today – Motley Fool


Motley Fool
Why Ultragenyx Pharmaceutical Stock Is Spiking Today
Motley Fool
Shares of the rare-disease drugmaker Ultragenyx Pharmaceutical (NASDAQ:RARE) rose by over 14% in pre-market trading on light volume Wednesday morning due to a positive phase 3 data readout for burosumab, the company’s experimental X-linked …
Ultragenyx Pharmaceutical Inc. Stock Shares Rise UpInvesting.com
Ultragenyx Pharmaceutical (RARE) Is Up On Phase 3 Study ResultsNasdaq
Ultragenyx Bounces Back, But Painful Questions RemainSeeking Alpha
Market Exclusive -Highland Mirror
all 35 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd